Omeros Stock Skyrockets After Novo Nordisk Strikes $2.1B Rare Disease Drug Deal

Why did Trump extend auto industry tariff relief? How is China’s rare earth export control affecting global markets? What impact will Boeing’s 737 Max production increase have? Why are Tesla shareholders urged to reject Musk’s pay plan? How is the government shutdown affecting federal infrastructure projects? What caused recent surge in US auto loan delinquencies? Why did Meta add parental controls for AI-teen interactions?

Omeros Stock Skyrockets After Novo Nordisk Strikes $2.1B Rare Disease Drug Deal

benzinga.com/news/health-care/25/10/48235727/omeros-stock-skyrockets-after-novo-nordisk-strikes-2-1b-rare-disease-drug-deal

Biotech breakthroughs are reshaping the pharmaceutical landscape, sparking lucrative deals and redefining the future of rare disease treatment. Omeros Corporation (NASDAQ:OMER) stock is rallying on Wednesday, with a session volume of 89.21 million versus the average volume of 1.11…

This story appeared on benzinga.com, 2025-10-15 18:58:04.